Back to Top Skip to main content Skip to sub-navigation

USU & JTS lead global COVID-19 Grand Rounds

Image of Woman in hospital bed surrounded by military health personnel. Click to open a larger version of the image. Service members aboard the USNS Comfort transport a screened COVID-19 patient during operations in New York City earlier this year. (Photo by Petty Officer 1st Class Joshua Sheppard.)

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

A 28-year-old was critically ill due to COVID-19. The patient seemed to improve at first, but within days, quickly developed a bacterial super-infection. Clinicians decided to use a novel blood purifying filter – a treatment to clear pathogens from a patient’s blood – as well as antibiotics, which dramatically helped improve the patient’s condition.

This unique case, and how it was successfully managed, was among the many COVID-related cases discussed during a Military Health System-wide virtual clinical case conference led by the Uniformed Services University and hosted by the Joint Trauma System.

In April, shortly after the start of the pandemic, USU began the weekly virtual conference in collaboration with the JTS. The medical education discussions are open to members of the Department of Defense medical community from across the globe, and hundreds have been dialing in each week to discuss the latest in collecting data, best practices, and lessons learned.

“The idea was to provide a virtual venue to allow clinicians in the Military Health System to share clinical findings and treatment strategies while also keeping them abreast of the latest developments in evaluation and treatment of COVID-19,” said Army Col. (Dr.) Kevin Chung, chair of USU’s Department of Medicine.

The weekly conferences – more than 20 to date – have provided updates from military experts, and an occasional civilian guest, in COVID-related clinical care, education, and research, as well as those experienced in performance improvement processes, such as developing patient data registries and evidence-based clinical practice guidelines.

“The main objective of this conference is to synchronize the MHS response to the COVID-19 pandemic and optimize the survival and recovery of those affected by the virus,” Chung said.

In addition to Chung, USU experts leading the calls have also included Air Force Col. (Dr.) Todd Rasmussen, a vascular surgeon and associate dean for research, Navy Capt. (Dr.) Timothy Burgess, director of USU’s Infectious Disease Clinical Research Program, and Dr. David Tribble, professor of Preventive Medicine and Biostatistics.

For more information about the grand rounds, visit www.deployedmedicine.com.

You also may be interested in...

DHA-Policy Memorandum 21-004: Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

6205.01

Policy

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

20-004

Policy

Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

3020.01, Change 2

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

3020.01, Change 1

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

  • Identification #: 20-003
  • Date: 5/13/2020
  • Type: Memorandums
  • Topics: Coronavirus
Showing results 1 - 12 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.